Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sight Sciences (SGHT) Receivables (2020 - 2026)

Sight Sciences has reported Receivables over the past 6 years, most recently at $9.7 million for Q4 2025.

  • For Q4 2025, Receivables fell 9.65% year-over-year to $9.7 million; the TTM value through Dec 2025 reached $9.7 million, down 9.65%, while the annual FY2025 figure was $9.7 million, 9.65% down from the prior year.
  • Receivables for Q4 2025 was $9.7 million at Sight Sciences, roughly flat from $9.7 million in the prior quarter.
  • Over five years, Receivables peaked at $19.9 million in Q2 2024 and troughed at $6.9 million in Q2 2021.
  • A 5-year average of $12.4 million and a median of $10.8 million in 2024 define the central range for Receivables.
  • Biggest five-year swings in Receivables: surged 73.94% in 2022 and later crashed 51.73% in 2025.
  • Year by year, Receivables stood at $8.7 million in 2021, then surged by 73.94% to $15.1 million in 2022, then fell by 5.67% to $14.3 million in 2023, then fell by 24.52% to $10.8 million in 2024, then dropped by 9.65% to $9.7 million in 2025.
  • Business Quant data shows Receivables for SGHT at $9.7 million in Q4 2025, $9.7 million in Q3 2025, and $9.6 million in Q2 2025.